DE602006020738D1 - Adjuvans oder pharmazeutische zubereitung zur transdermalen oder transmukosalen verabreichung - Google Patents
Adjuvans oder pharmazeutische zubereitung zur transdermalen oder transmukosalen verabreichungInfo
- Publication number
- DE602006020738D1 DE602006020738D1 DE602006020738T DE602006020738T DE602006020738D1 DE 602006020738 D1 DE602006020738 D1 DE 602006020738D1 DE 602006020738 T DE602006020738 T DE 602006020738T DE 602006020738 T DE602006020738 T DE 602006020738T DE 602006020738 D1 DE602006020738 D1 DE 602006020738D1
- Authority
- DE
- Germany
- Prior art keywords
- adjuvans
- transdermal
- pharmaceutical preparation
- transmucosal administration
- transmucosal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Radiology & Medical Imaging (AREA)
- Wood Science & Technology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005222749 | 2005-08-01 | ||
PCT/JP2006/315103 WO2007015441A1 (ja) | 2005-08-01 | 2006-07-31 | 経皮または経粘膜投与のためのアジュバントおよび製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006020738D1 true DE602006020738D1 (de) | 2011-04-28 |
Family
ID=37708721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006020738T Active DE602006020738D1 (de) | 2005-08-01 | 2006-07-31 | Adjuvans oder pharmazeutische zubereitung zur transdermalen oder transmukosalen verabreichung |
Country Status (5)
Country | Link |
---|---|
US (3) | US20090130127A1 (de) |
EP (1) | EP1917976B1 (de) |
JP (1) | JP5006196B2 (de) |
DE (1) | DE602006020738D1 (de) |
WO (1) | WO2007015441A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
JP5275047B2 (ja) * | 2007-01-31 | 2013-08-28 | 久光製薬株式会社 | 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 |
JPWO2009044555A1 (ja) * | 2007-10-04 | 2011-02-03 | 学校法人 城西大学 | 製剤、当該製剤を用いたワクチンの投与方法及びイオントフォレーシス装置 |
KR101578420B1 (ko) | 2008-06-30 | 2015-12-17 | 히사미쓰 세이야꾸 가부시키가이샤 | 마이크로니들 디바이스 및 마이크로니들 디바이스에 의한 인플루엔자 백신의 주공성을 상승시키는 방법 |
KR101622738B1 (ko) * | 2008-07-30 | 2016-05-19 | 히사미쓰 세이야꾸 가부시키가이샤 | 마이크로니들 디바이스 및 마이크로니들 디바이스에 의한 일본 뇌염 바이러스 항원의 주효성을 상승시키는 방법 |
JP2010037214A (ja) * | 2008-07-31 | 2010-02-18 | Shiseido Co Ltd | 薬剤の浸透促進方法 |
US20110159035A1 (en) * | 2008-08-01 | 2011-06-30 | Masahiro Goto | S/o type transdermal immunizing agent |
JP5606683B2 (ja) * | 2009-02-25 | 2014-10-15 | 帝國製薬株式会社 | ケトロラックの経皮吸収用組成物 |
WO2012115222A1 (ja) * | 2011-02-25 | 2012-08-30 | 久光製薬株式会社 | 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 |
KR102058979B1 (ko) * | 2011-03-07 | 2019-12-24 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 마이크로니들 장치 및 방법 |
JP2014525458A (ja) * | 2011-08-31 | 2014-09-29 | ペロスフィア インコーポレイテッド | アレルギー患者を有効かつ迅速に脱感作するための方法 |
EP2764887B1 (de) | 2011-10-06 | 2020-12-02 | Hisamitsu Pharmaceutical Co., Inc. | Applikator |
JP6370802B2 (ja) * | 2012-12-28 | 2018-08-08 | テイコク ファーマ ユーエスエー インコーポレーテッド | 持続性ブプレノルフィン経皮送達組成物およびそれの使用方法 |
KR20140100422A (ko) | 2013-02-05 | 2014-08-14 | 닛토덴코 가부시키가이샤 | 백신 조성물 |
EP2762157A1 (de) * | 2013-02-05 | 2014-08-06 | Nitto Denko Corporation | Impfstoffzusammensetzung zur transdermalen oder mukosalen Verabreichung |
US9993549B2 (en) | 2013-10-31 | 2018-06-12 | Hisamitsu Pharmaceutical Co., Inc. | Adjuvant composition, adjuvant preparation containing same, and kit |
US10585086B2 (en) | 2014-06-12 | 2020-03-10 | Hyglos Invest Gmbh | Unmasking endotoxins in solution |
EP3470840B1 (de) | 2014-06-12 | 2021-03-03 | Hyglos Invest GmbH | Demaskierung von Endotoxinen in Lösung |
US11160753B2 (en) * | 2015-03-02 | 2021-11-02 | Medlab Clinical U.S., Inc. | Transmucosal and transdermal delivery systems |
CN110198703A (zh) | 2016-11-21 | 2019-09-03 | 艾里奥治疗公司 | 大试剂的透皮递送 |
JP6482604B2 (ja) * | 2017-06-22 | 2019-03-13 | 教裕 南郷 | 外皮内溶解型ニードル及びニードル装置 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4590190A (en) * | 1983-07-01 | 1986-05-20 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
US4605670A (en) * | 1984-02-01 | 1986-08-12 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering metoclopramide |
JP2913229B2 (ja) * | 1991-10-21 | 1999-06-28 | 塩野義製薬株式会社 | 油性アジュバントワクチン製剤 |
JPH05255112A (ja) * | 1992-03-14 | 1993-10-05 | Kanebo Ltd | アジュバント組成物 |
DE69533693T2 (de) | 1994-02-24 | 2005-12-22 | Novavax Inc.(n.d.Ges.d.Staates Delaware) | Impfstoffe, die paucilamelläre Lipidvesikel als Adjuvans enthalten |
AU6046198A (en) * | 1997-01-31 | 1998-08-25 | Kenneth Hoyt | Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
IS4518A (is) | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
ATE356620T1 (de) * | 1998-04-20 | 2007-04-15 | Torrey Pines Inst | Topische immunostimulierung zur induzierung der migration der langerhanszellen |
CA2372409C (en) | 1999-01-28 | 2005-03-29 | Alan D. King | Delivery of macromolecules into cells |
PL355163A1 (en) | 1999-09-24 | 2004-04-05 | Smithkline Beecham Biologicals S.A. | Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
DE10019171A1 (de) * | 2000-04-07 | 2001-10-18 | Schering Ag | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
GB0017999D0 (en) | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
CA2420601A1 (en) | 2000-08-31 | 2003-02-26 | The Kitasato Institute | Vaccine preparation containing fatty acid as component |
AR030829A1 (es) | 2000-10-02 | 2003-09-03 | Smithkline Beecham Biolog | Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal |
AU2002252378B2 (en) | 2001-03-19 | 2007-10-18 | Intercell Usa, Inc. | Transcutaneous immunostimulation |
IL142536A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Carriers for therapeutic preparations for treatment of t-cell mediated diseases |
US20020193729A1 (en) | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
DE60233939D1 (de) | 2001-04-20 | 2009-11-19 | Alza Corp | Mikroprojektionsanordnung mit einem überzug, der ein vorteilhaftes mittel enthält |
US7914799B2 (en) | 2001-08-27 | 2011-03-29 | Immunitor USA, Inc. | Anti-fungal composition |
AU2003205979A1 (en) * | 2002-02-25 | 2003-09-09 | Lyfjathroun Hf, Biopharmaceutical Research | An immunological adjuvant |
JP4213432B2 (ja) | 2002-08-28 | 2009-01-21 | 久光製薬株式会社 | 貼付剤 |
MXPA06001414A (es) | 2003-08-04 | 2006-08-25 | Johnson & Johnson | Metodo y dispositivo para incrementar el flujo de agente transdermico. |
AU2004285484A1 (en) | 2003-10-24 | 2005-05-12 | Alza Corporation | Pretreatment method and system for enhancing transdermal drug delivery |
-
2006
- 2006-07-31 DE DE602006020738T patent/DE602006020738D1/de active Active
- 2006-07-31 JP JP2007529246A patent/JP5006196B2/ja active Active
- 2006-07-31 US US11/997,413 patent/US20090130127A1/en not_active Abandoned
- 2006-07-31 WO PCT/JP2006/315103 patent/WO2007015441A1/ja active Application Filing
- 2006-07-31 EP EP06781981A patent/EP1917976B1/de active Active
-
2012
- 2012-02-07 US US13/367,679 patent/US8858962B2/en active Active
-
2014
- 2014-07-28 US US14/444,149 patent/US20150071970A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1917976A1 (de) | 2008-05-07 |
US20090130127A1 (en) | 2009-05-21 |
US20120156258A1 (en) | 2012-06-21 |
EP1917976A4 (de) | 2008-12-03 |
EP1917976B1 (de) | 2011-03-16 |
JPWO2007015441A1 (ja) | 2009-02-19 |
US20150071970A1 (en) | 2015-03-12 |
US8858962B2 (en) | 2014-10-14 |
JP5006196B2 (ja) | 2012-08-22 |
WO2007015441A1 (ja) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006020738D1 (de) | Adjuvans oder pharmazeutische zubereitung zur transdermalen oder transmukosalen verabreichung | |
EP1898922A4 (de) | Verbessertes arzneimittel oder pharmazeutische verbindungen und eine zubereitung davon | |
IL184758A0 (en) | New pharmaceutical compositions useful in the transmucosal administration of drugs | |
BRPI0616703A2 (pt) | forma de dosagem farmacêutica | |
HK1084590A1 (en) | Pharmaceutical composition for transdermal or transmucosal administration | |
DK2399580T3 (da) | Farmaceutiske doseringsformer | |
ATE517619T1 (de) | Stabilisierte pharmazeutische zusammensetzung mit fesoterodin | |
IL185390A (en) | A solid dosage form | |
ATE532788T1 (de) | Pharmazeutische verbindungen | |
DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
NO20085415L (no) | Farmasøytisk doseringsform inneholdende fenylefrin med vedvarende frigivelse | |
ATE493119T1 (de) | Pharmazeutische zusammensetzung | |
DE602005007873D1 (de) | Röntgensichtbare arzneimittelabgabevorrichtung | |
ATE489944T1 (de) | Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür | |
DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
ATE439832T1 (de) | Feste pharmazeutische arzneimittelformulierung enthaltend diacerein und meloxicam | |
EP2123296A4 (de) | Hilfsstoff für transdermale oder transmukosale verabreichung und pharmazeutische zubereitung damit | |
EP1948138A4 (de) | Segmentierte pharmazeutische dosierformen | |
DE502006001195D1 (de) | Transdermales therapeutisches system zur verabreichung von analgetika | |
ZA200803152B (en) | Oramucosal pharmaceutical dosage form | |
DE502008002926D1 (de) | Kosmetische oder Pharmazeutische Zubereitung | |
FR2873294B1 (fr) | Association de medicaments | |
ATE486633T1 (de) | Feste pharmazeutische zusammensetzung mit telithromycin | |
DK1784174T3 (da) | Famaceutisk sammensætning omfattende gabapentin | |
ATE501729T1 (de) | Adjuvans oder pharmazeutische zubereitung zur transdermalen oder transmukosalen verabreichung |